Martin Baccardax

Global oil prices extended gain again Tuesday, taking U.S. crude past the $62 mark for the first time in nearly five months, following stronger-than-expected factory output data from the U.S. and China and reports that Washington may revoke waivers for the purchase of Iranian exports.

The U.K.'s Brexit crisis deepened Tuesday as the European Union's chief negotiator warned Britain faces crashing out of the bloc in ten day's time unless lawmakers can find a way out of the current impasse.

Lyft shares slumped below their original listing price on the second full-day of trading on the Nasdaq Monday following the ride-sharing group's blockbuster IPO last week, the biggest in five years, that raised $2.34 billion and dominated Wall Street trading.

Global oil prices traded firmly higher Monday, extending gains from the strongest quarter in a decade, after stronger-than-expected factory output data from China and ongoing production cuts from OPEC member and its allies raised the prospect of increasing demand into the summer months.

Apple shares traded sharply lower Monday, reversing earlier gains, following a report that suggested the tech giant has slashed sale prices for its iPhone and Mac products in China.

Merck shares edged higher Monday after the drugmaker won approval for the sale of its blockbuster lung cancer treatment in China.

Facebook shares traded higher Monday following a weekend editorial from founder and CEO Mark Zuckerberg that called for a larger government rule in policing the internet amid reports the social media group faces a multi-billion dollar fine over its privacy failures.

U.S. equities capped their strongest three month gain in a decade over the first quarter, while the economy continues to expand and the jobless rate sits at the lowest level in a generation, but President Donald Trump and his team think the Federal Reserve should move quickly to cut interest rates in order to ensure the current boom remains on track.

Global stocks rebounded firmly Monday, boosted by the strongest reading of manufacturing output in China in at least eight months and further suggestions of trade talk progress between Washington and Beijing, although gains were capped by weaker factory output readings across Europe in Japan.

Celgene surges Friday after an influential shareholder advisory group recommend investors vote in favor of the cancer drug specialist's takeover by Bristol-Myers Squibb Co. while a key activist dropped its opposition to the $74 billion deal.